B+
Bull case
20%
Probability
Target price
$38.50
+17.1% vs current
AXTA
Axalta CoatingANYSE / Materials
Last Price
At close
2026-07-18
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$31.50
-4.2% vs current
B-
Bear case
30%
Probability
Target price
$27.00
-17.9% vs current
AI sentiment snapshot
Latest data as of 2026-07-18
Recent news sentiment (30D)
+18.3
Positive
Company
-
Unavailable
Macro
+18.9
Positive
Pulse
-45.0
Negative
Sentiment proxy
+43.6
Score
AI commentary
Visible news flow is sparse and primarily transaction- or earnings-schedule-driven. Primary operating evidence supports monitoring rather than a high-conviction bullish thesis; analyst revision visibility, options data, short interest, social coverage, and post-release price reaction are unavailable.
RankAlpha Sentiment Codex - 2026-07-18
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-07-28catalystQ2 earnings checkpoint tests maintained outlookMedium impact
Axalta exceeded Q1 guidance, but sales declined year over year and Refinish volumes and price mix weakened in North America. The July 28 Q2 report is the next test of pricing, cost discipline, margins, and the FY 2026 outlook of $1.14-$1.17 billion adjusted EBITDA and $2.55-$2.70 adjusted EPS [#SEC-8K-2026-04-30] [#PR-EARNINGS-2026-07-06].
2026-08-05eventAkzoNobel merger stockholder voteHigh impact
The proposed AkzoNobel merger remains the clearest near-term binary event. Axalta disclosed that the Form F-4 was effective, a definitive proxy was filed, and a special meeting was scheduled for August 5, 2026; shareholder and regulatory approvals remain required [#IR-2026-06-24].
2027-01-15catalystMerger execution and operating disciplineHigh impact
Management reported progress toward the proposed merger and emphasized pricing strategies, cost discipline, operational efficiencies, and integration planning. Successful execution could support a rerating, but the timing and benefits remain uncertain [#SEC-8K-2026-04-30].
Recommendation
N/A
No formal recommendation provided.
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology